Literature DB >> 9178164

Amyotrophic lateral sclerosis: from pathological mechanisms to patient care.

G Scarlato1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178164     DOI: 10.1007/BF03160573

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  14 in total

Review 1.  Risk factors in amyotrophic lateral sclerosis.

Authors:  J F Kurtzke
Journal:  Adv Neurol       Date:  1991

Review 2.  Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis.

Authors:  J D Rothstein
Journal:  Adv Neurol       Date:  1995

3.  Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.

Authors:  L Lacomblez; G Bensimon; P N Leigh; P Guillet; V Meininger
Journal:  Lancet       Date:  1996-05-25       Impact factor: 79.321

4.  Prognostic factors and survival in amyotrophic lateral sclerosis.

Authors:  O B Tysnes; S E Vollset; J P Larsen; J A Aarli
Journal:  Neuroepidemiology       Date:  1994       Impact factor: 3.282

Review 5.  Excitotoxicity and motor neurone disease: a review of the evidence.

Authors:  P J Shaw
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

6.  Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole.

Authors:  T Hebert; P Drapeau; L Pradier; R J Dunn
Journal:  Mol Pharmacol       Date:  1994-05       Impact factor: 4.436

7.  Onset, natural history and outcome in idiopathic adult motor neuron disease.

Authors:  F Norris; R Shepherd; E Denys; K U; E Mukai; L Elias; D Holden; H Norris
Journal:  J Neurol Sci       Date:  1993-08       Impact factor: 3.181

8.  Increasing trend of ALS in France and elsewhere: are the changes real?

Authors:  S Durrleman; A Alperovitch
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

9.  Amyotrophic lateral sclerosis. Communication status and survival with ventilatory support.

Authors:  J R Bach
Journal:  Am J Phys Med Rehabil       Date:  1993-12       Impact factor: 2.159

10.  The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1.

Authors:  D Martin; M A Thompson; J V Nadler
Journal:  Eur J Pharmacol       Date:  1993-12-21       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.